These 28-week data on twice-daily ESK-001 highlight the drug’s safety and efficacy among patients with psoriasis.
In recent years, it’s been estimated that 10% to 28% of patients with myeloid disorders develop adult onset inflammatory and ...
A new study highlights risk factors for hospitalization and severe illness among adults with respiratory syncytial virus (RSV ...
Increased time spent on discussing testing for colorectal cancer (CRC) was associated with patient satisfaction in older ...
Initial evidence suggests alternative approaches such as exercise, dietary modification, and psychosocial therapies may ...
The extent to which certified community behavioral health clinic expansion reaches different parts of the country remained ...
The approval came days before the FDA’s expected deadline and makes this the only PD-1 inhibitor approved for resectable ...
Most patients diagnosed with chronic-phase chronic myeloid leukemia (CP-CML) who achieved a deep molecular response on ...
The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years.
On September 20, the FDA approved isatuximab plus bortezomib, lenalidomide, and dexamethasone in the first line for patients ...
Panelists discuss how immunotherapies like durvalumab and atezolizumab have emerged as promising treatments for ...
Higher pre- and postdiagnosis Alternate Mediterranean Diet (AMED) scores are associated with improved overall survival in patients with ovarian cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback